Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.8752
-0.0260 (-2.89%)
Jul 31, 2026, 3:18 PM EDT - Market open

Lucid Diagnostics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.134.714.352.430.380.5
Revenue Growth
23.03%8.28%79.00%544.03%-24.60%-
Gross Profit
-1.61-1.96-2.75-3.55-3.24-0.09
Operating Income
-49.27-49.64-46.05-48.48-56.25-27.42
Net Income
-58.18-70.57-53.03-52.67-56.17-28.08
Earnings Per Share
-0.47-0.69-1.05-1.05-0.90-1.05
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
27.8834.7122.3618.922.4753.66
Total Debt
26.825.8221.2515.2620
Net Cash (Debt)
1.078.891.13.6420.4853.66
Net Cash Growth
-704.80%-69.68%-82.22%-61.84%48238.74%
Net Cash Per Share
0.010.090.020.070.332.00

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-46.12-46.49-44.14-32.82-29.69-17.67
Capital Expenditures
-0.32-0.2-0.3-0.22-0.91-0.86
Free Cash Flow
-46.44-46.68-44.44-33.04-30.59-18.53
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-31.38%-41.73%-63.35%-146.25%-858.62%-17.00%
Operating Margin
-959.64%-1054.82%-1059.64%-1996.79%-14920.70%-5483.80%
Pretax Margin
-876.72%-1232.68%-1047.61%-2169.11%-14899.47%-5615.60%
Profit Margin
-876.72%-1232.68%-1047.61%-2169.11%-14899.50%-5615.60%
FCF Margin
-904.56%-991.97%-1022.46%-1360.71%-8114.85%-3706.00%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
33.4930.3711.8829.50210.48540.03